World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
13530
World Ranking
4121
National Ranking
1879

Overview

Nancy L. Reinsmoen is affiliated with Cedars-Sinai Medical Center in the United States. Their research primarily spans the field of medicine, with a focus on surgery, transplantation, infectious diseases, oncology, and epidemiology.

Their scholarly work includes studies on renal transplantation outcomes and treatments, methods and outcomes of transplantation, organ transplantation techniques and outcomes, research related to SARS-CoV-2 and COVID-19, viral-associated cancers and disorders, cytomegalovirus and herpesvirus research, and the complement system in diseases.

The scientist has authored several recent papers, including:

  • Impact and production of Non-HLA-specific antibodies in solid organ transplantation (2020, International Journal of Immunogenetics)
  • Use of Rituximab for persistent EBV DNAemia, and Its effect on donor-specific antibody development in pediatric renal transplant recipients: A case series (2021, Pediatric Transplantation)
  • HLA Mismatches Identified by a Novel Algorithm Predict Risk of Antibody-mediated Rejection From De Novo Donor-specific Antibodies (2024, Transplantation)

Frequent co-authors collaborating with Nancy L. Reinsmoen include Xiaohai Zhang, Dechu Puliyanda, Stanley C. Jordan, Irene Kim, and Mitasha Patel.

Publication venues associated with their work are the International Journal of Immunogenetics, Pediatric Transplantation, and Transplantation.

Best Publications

  • Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

    Ashley A Vo;Marina Lukovsky;Mieko Toyoda;Jennifer Wang

  • Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation

    Deborah J. Levine;Allan R. Glanville;Christina Aboyoun;John Belperio

  • Report from a consensus conference on antibody-mediated rejection in heart transplantation

    Jon Kobashigawa;Maria G. Crespo-Leiro;Stephan M. Ensminger;Hermann Reichenspurner

  • The molecular basis of alloreactivity.

    Robert I Lechler;Giovanna Lombardi;J Richard Batchelor;Nancy Reinsmoen

  • Acute antibody-mediated rejection of cardiac transplants.

    Elaine F. Reed;Anthony J. Demetris;Elizabeth Hammond;Silviu Itescu

  • Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.

    Ashley A. Vo;Alice Peng;Mieko Toyoda;Joseph Kahwaji

  • WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPIENTS

    Hector C. Ramos;Jorge Reyes;Kareem Abu-Elmagd;Adriana Zeevi

  • Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.

    Nancy L. Reinsmoen;Chih Hung Lai;Harald Heidecke;Mark Haas

  • The role of innate immunity in acute allograft rejection after lung transplantation.

    Scott M. Palmer;Lauranell H. Burch;R. Duane Davis;Walter F. Herczyk

  • Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection.

    Paulo N. Rocha;David W. Butterly;Arthur Greenberg;Donal N. Reddan

  • A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients

    Ashley A. Vo;Jua Choi;Irene Kim;Sabrina Louie

  • Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.

    Scott M. Palmer;R. Duane Davis;Denis Hadjiliadis;Marshall I. Hertz

  • Five HLA-D clusters associated with HLA-DR4.

    Nancy L. Reinsmoen;Fritz H. Bach

  • Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.

    Nancy L. Reinsmoen;Chih Hung Lai;Ashley Vo;Kai Cao

  • Implications for Human Leukocyte Antigen Antibodies After Lung Transplantation: A 10-Year Experience in 441 Patients

    Laurie D. Snyder;Ziwei Wang;Dong-Feng Chen;Nancy L. Reinsmoen

  • A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients.

    Ashley A. Vo;Adriana Zeevi;Jua Choi;Kristen Cisneros

  • Report from a consensus conference on the sensitized patient awaiting heart transplantation.

    Jon Kobashigawa;Mandeep Mehra;Lori West;Ronald Kerman

  • Innate immunity influences long-term outcomes after human lung transplant.

    Scott M. Palmer;Lauranell H. Burch;Anil J. Trindade;R. Duane Davis

  • Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients.

    Ashley A. Vo;Jua Choi;Kristen Cisneros;Nancy Reinsmoen

  • The management of antibodies in heart transplantation: An ISHLT consensus document

    Jon Kobashigawa;Monica Colvin;Luciano Potena;Duska Dragun

  • Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome.

    Nancy L. Reinsmoen;Chih Hung Lai;James Mirocha;Kai Cao

Frequent Co-Authors

Arthur J. Matas
Arthur J. Matas University of Minnesota
Edmond J. Yunis
Edmond J. Yunis Harvard University
Marshall I. Hertz
Marshall I. Hertz University of Minnesota
John H. Kersey
John H. Kersey University of Minnesota
John S. Najarian
John S. Najarian University of Minnesota
David E.R. Sutherland
David E.R. Sutherland University of Minnesota
Carolyn Katovich Hurley
Carolyn Katovich Hurley Georgetown University
John A. Hansen
John A. Hansen Fred Hutchinson Cancer Research Center
Bo Dupont
Bo Dupont Kettering University
Peter K. Gregersen
Peter K. Gregersen Feinstein Institute for Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through related online degrees can open diverse career opportunities. One viable option is pursuing nurse practitioner programs, which offer specialized knowledge in patient care and disease management. If you are considering this path, exploring which nurse practitioner program is easiest can help you find the right balance between flexibility and academic rigor.

For professionals focused on mental health, online Psychiatric Mental Health Nurse Practitioner (PMHNP) programs provide advanced training and clinical experience. Programs with the best pmhnp programs online ensure strong clinical placement rates, critical for hands-on practice and career readiness.

Cost is an important consideration when selecting a program. Many students prioritize affordability without compromising quality. To assist with budgeting, you can review options featuring the cheapest online pmhnp programs, which can offer excellent training at a lower cost.

Ultimately, understanding the financial outlook for advanced degrees is key. Salaries vary widely by specialty and location, so comparing dnp salary by specialty can provide valuable insight into potential earnings and inform your career planning.

Best Scientists Citing Nancy L. Reinsmoen

Trending Scientists

Recently Published Articles